CELMoDs – The Future of Multiple Myeloma Treatment..

新しい記事を作成しました

35 の

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID | #healthcare

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID

The field of multiple myeloma treatment is advancing rapidly, with CELMoDs (Cereblon E3 Ligase Modulators) emerging as a powerful alternative to Revlimid.

お気に入り嫌い

コメント

シェア